Form 8-K - Current report:
SEC Accession No. 0000950170-25-087429
Filing Date
2025-06-17
Accepted
2025-06-17 16:38:19
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K itos-20250617.htm   iXBRL 8-K 56932
  Complete submission text file 0000950170-25-087429.txt   163571

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itos-20250617.xsd EX-101.SCH 24894
12 EXTRACTED XBRL INSTANCE DOCUMENT itos-20250617_htm.xml XML 4704
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39401 | Film No.: 251053860
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)